In Western countries, educational campaigns and various early PCa detection programs, primary based on regular prostate-specific antigen (PSA) measurements, resulted in earlier PCa detection, followed by a higher likelihood of curative treatment in the majority of patients. Here, KLK3 is linked to posterior cortical atrophy.